Clinicopathologic and molecular characteristics of small-scale ROS1-mutant non-small cell lung cancer (NSCLC) patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinicopathologic and molecular characteristics of small-scale ROS1-mutant non-small cell lung cancer (NSCLC) patients

Published:2023-10 Issue: Volume:184 Page:107344
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Glaser Moritz^ORCID,Rasokat Anna,Prang Darinka,Nogova Lucia,Wömpner Claudia,Schmitz Jaqueline,Bitter Elisabeth,Terjung Inken,Eisert Anna,Fischer Rieke,John Felix,von Levetzow Cornelia,Michels Sebastian,Riedel Richard,Ruge Lea,Scharpenseel Heather,Siebolts Udo,Merkelbach-Bruse Sabine,Buettner Reinhard,Brägelmann Johannes,Wolf Jürgen,Scheffler Matthias^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference26 articles.

1. ROS1-dependent cancers — biology, diagnostics and therapeutics;Drilon;Nat. Rev. Clin. Oncol.,2021

2. ROS1 -Rearranged Non–Small-Cell Lung Cancer, N. Engl. J. Med. 372 (2015) 683–684. https://doi.org/10.1056/NEJMc1415359.

3. Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001;Shaw;Ann. Oncol.,2019

4. Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS): A European Phase II Clinical Trial;Michels;J. Thorac. Oncol.,2019

5. Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive Non–Small-Cell Lung Cancer;Dziadziuszko;J. Clin. Oncol.,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP